{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:03:29Z","timestamp":1790269409141,"version":"4.1.0"},"reference-count":21,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA254926"],"award-info":[{"award-number":["R37CA254926"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Med Decis Making"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>From 2009 to 2024, the US Preventive Services Task Force (USPSTF) recommended that women aged 40 to 49 y make an informed choice about when to begin having mammograms. In 2024, the USPSTF changed its guidelines, recommending biennial screening from age 40 to 74 y. This study investigated women\u2019s attitudes toward the guideline change. Moreover, since the evidence for screening benefit and harm changed very little from past estimates, a randomized experiment tested whether providing this information would affect participants\u2019 evaluations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>A total of 466 women aged 39 to 49 y without a history of breast cancer were enrolled in a longitudinal study and exposed to a mammography decision aid (DA). After the USPSTF guideline was announced in April 2024, these participants were recontacted to take a survey informing them of the guideline change and asking them to report their attitudes toward it. In total, 301 (mean age = 43.3 y, SD = 2.9 y; 68.4% White; 9.0% Hispanic) participants took the survey and were randomized into 1 of two conditions, one presenting basic information about the guideline change and the other additionally communicating updated benefit and harm data. Outcomes included attitudes toward the new guideline and associated rationales, trust in the USPSTF, and perceived mammography benefit and harm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The experimental conditions had no effect on any outcome (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      s &gt; 0.05). On average, attitudes toward the new guideline were positive (61% \u201cpositive\u201d or \u201cvery positive\u201d), trust in the USPSTF was moderately high (M = 5.57, SD = 1.00, 1\u20137 scale), and participants perceived high screening benefit (M = 4.34, SD = 0.80; 1\u20135 scale) and low harm (M = 1.81, SD = 0.73; 1\u20135 scale). Differences of opinion were observed regarding screening frequency, suggesting that screening frequency is preference sensitive.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Most women evaluated the 2024 USPSTF guideline positively, trusted the USPSTF, and perceived screening as beneficial and minimally harmful. There was no evidence that women\u2019s attitudes were influenced by the minimal change in evidence for mammography benefit and harm.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/0272989x261484970","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:47:51Z","timestamp":1790063271000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Women\u2019s Attitudes toward the 2024 US Preventive Services Task Force Mammography Screening Guideline"],"prefix":"10.1177","author":[{"given":"Grant","family":"Yoder","sequence":"first","affiliation":[{"name":"Adult and Child Center for Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, CO, USA"},{"name":"Department of Health and Behavioral Sciences, University of Colorado Denver, Denver, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2425-0181","authenticated-orcid":false,"given":"Tamar","family":"Parmet","sequence":"additional","affiliation":[{"name":"Adult and Child Center for Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, CO, USA"},{"name":"Department of Psychology, University of Colorado Denver, Denver, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten J.","family":"McCaffery","sequence":"additional","affiliation":[{"name":"Sydney Health Literacy Lab, School of Public Health, The University of Sydney, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolyn","family":"Hersch","sequence":"additional","affiliation":[{"name":"Sydney Health Literacy Lab, School of Public Health, The University of Sydney, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3775-9462","authenticated-orcid":false,"given":"Marilyn M.","family":"Schapira","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Philadelphia VA Medical Center, Philadelphia PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen L.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph N.","family":"Cappella","sequence":"additional","affiliation":[{"name":"Annenberg School for Communication, University of Pennsylvania, Philadelphia PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Morse","sequence":"additional","affiliation":[{"name":"Adult and Child Center for Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6635-9794","authenticated-orcid":false,"given":"Channing E.","family":"Tate","sequence":"additional","affiliation":[{"name":"Adult and Child Center for Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Smyth","sequence":"additional","affiliation":[{"name":"Adult and Child Center for Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Mosley","sequence":"additional","affiliation":[{"name":"Adult and Child Center for Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8660-7115","authenticated-orcid":false,"given":"Laura D.","family":"Scherer","sequence":"additional","affiliation":[{"name":"Adult and Child Center for Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, CO, USA"},{"name":"Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"Marmot MG et al. The benefits and harms of breast cancer screening: an independent review: a report jointly commissioned by Cancer Research UK and the Department of Health (England) October 2012. Br J Cancer. 2013;108(11):2205\u20132240. https:\/\/doi.org\/10.1038\/bjc.2013.177","DOI":"10.1038\/bjc.2013.177"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","unstructured":"Vass CM Rigby D Payne K. Investigating the heterogeneity in women\u2019s preferences for breast screening: does the communication of risk matter? Value Health. 2018;21(2):219\u2013228. https:\/\/doi.org\/10.1016\/j.jval.2017.07.010","DOI":"10.1016\/j.jval.2017.07.010"},{"key":"e_1_3_2_4_2","unstructured":"Welch HG Schwartz L Woloshin S. Overdiagnosed: making people sick in the pursuit of health. Beacon Press; 2012."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2307229"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","unstructured":"US Preventive Services Task Force. Screening for breast cancer: US preventive services task force recommendation statement. JAMA. 2024;331(22):1918\u20131930. https:\/\/doi.org\/10.1001\/jama.2024.5534","DOI":"10.1001\/jama.2024.5534"},{"key":"e_1_3_2_7_2","unstructured":"National Cancer Institute. SEER*stat databases: November 2021 submission. 2021; [accessed 2026 Mar 18]. https:\/\/seer.cancer.gov\/data-software\/documentation\/seerstat\/nov2021\/index.html"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","unstructured":"Henderson JT Webber EM Weyrich M Miller M Melnikow J. Screening for breast cancer: a comparative effectiveness review for the U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality (US); 2024. [accessed 2025 Jan 24]. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK603789\/","DOI":"10.1001\/jama.2023.25844"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","unstructured":"Harris RP. The new proposed U.S. Preventive Services Task Force recommendation on breast cancer screening for women in their 40s: should the message change? Ann Intern Med. 2024;177(3):389\u2013392. https:\/\/doi.org\/10.7326\/M23-2908","DOI":"10.7326\/M23-2908"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.1279"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.0905"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-008-0575-3"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","unstructured":"Mehta JM et al. Breast cancer screening: women\u2019s attitudes and beliefs in light of updated United States Preventive Services Task Force and American Cancer Society Guidelines. J Womens Health. 2019;28(3):302\u2013313. https:\/\/doi.org\/10.1089\/jwh.2017.6885","DOI":"10.1089\/jwh.2017.6885"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","unstructured":"Squiers LB et al. The public\u2019s response to the U.S. Preventive Services Task Force\u2019s 2009 recommendations on mammography screening. Am J Prev Med. 2011;40(5):497\u2013504. https:\/\/doi.org\/10.1016\/j.amepre.2010.12.027","DOI":"10.1016\/j.amepre.2010.12.027"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","unstructured":"Kiviniemi MT Hay JL. Awareness of the 2009 US Preventive Services Task Force recommended changes in mammography screening guidelines accuracy of awareness sources of knowledge about recommendations and attitudes about updated screening guidelines in women ages 40\u201349 and 50+. BMC Public Health. 2012;12(1):899. https:\/\/doi.org\/10.1186\/1471-2458-12-899","DOI":"10.1186\/1471-2458-12-899"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","unstructured":"Scherer LD et al. Mammography screening preferences among screening-eligible women in their 40s. Ann Intern Med. 2024;177(8):1069\u20131077. https:\/\/doi.org\/10.7326\/M23-3325","DOI":"10.7326\/M23-3325"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","unstructured":"Mathioudakis AG et al. Systematic review on women\u2019s values and preferences concerning breast cancer screening and diagnostic services. Psycho-Oncology. 2019;28(5):939\u2013947. https:\/\/doi.org\/10.1002\/pon.5041","DOI":"10.1002\/pon.5041"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","unstructured":"Nosratnejad S Rahmani S Yousefi M Khabiri R. Assessing women\u2019s stated preferences for breast cancer screening: a systematic review and a meta-analysis. BMC Health Serv Res. 2024;24(1):1501. https:\/\/doi.org\/10.1186\/s12913-024-11847-7","DOI":"10.1186\/s12913-024-11847-7"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","unstructured":"Morse B et al. Evaluation of how US women react to a decision aid informing them of the harms and benefits of mammography: a qualitative study. BMJ Open. 2025;15(3):e087997. https:\/\/doi.org\/10.1136\/bmjopen-2024-087997","DOI":"10.1136\/bmjopen-2024-087997"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","unstructured":"Hersch J et al. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet. 2015;385(9978):1642\u20131652. https:\/\/doi.org\/10.1016\/S0140-6736(15)60123-4","DOI":"10.1016\/S0140-6736(15)60123-4"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","unstructured":"Waller J Douglas E Whitaker KL Wardle J. Women\u2019s responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study: Table 1. BMJ Open. 2013;3(4):e002703. https:\/\/doi.org\/10.1136\/bmjopen-2013-002703","DOI":"10.1136\/bmjopen-2013-002703"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","unstructured":"Hersch J et al. Informing women about overdetection in breast cancer screening: two-year outcomes from a randomized trial. J Natl Cancer Inst. 2021;113(11):1523\u20131530. https:\/\/doi.org\/10.1093\/jnci\/djab083","DOI":"10.1093\/jnci\/djab083"}],"container-title":["Medical Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0272989X261484970","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0272989X261484970","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0272989X261484970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:22:51Z","timestamp":1790266971000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0272989X261484970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":21,"alternative-id":["10.1177\/0272989X261484970"],"URL":"https:\/\/doi.org\/10.1177\/0272989x261484970","relation":{},"ISSN":["0272-989X","1552-681X"],"issn-type":[{"value":"0272-989X","type":"print"},{"value":"1552-681X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"0272989X261484970"}}